Skip to content

An Ayurvedic medicinal herb in the management of complications occuring due to early removal of uterus

Efficacy of Shankapushpi churna in Post Hysterectomy Menopausal Syndrome - A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047631
Enrollment
30
Registered
2022-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z907- Acquired absence of genital organ(s)

Interventions

None listed

Sponsors

Dr Dharthy Shankar Budihal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Women below the age of 50 years, undergone hysterectomy before attaining natural menopause, with or without oophorectomy 2)Minimum period of post hysterectomy – 3 months 3)Women with minimal Menopausal Rating Scale score of 5 & Modified Kuppermans Index score of 7

Exclusion criteria

Exclusion criteria: 1)Women on any hormonal therapy 2)Women with K/C/O uncontrolled medical conditions such as Hypertension, Diabetes mellitus, Coronary vessel disease, Neurological disease, Psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Shankapushpi churna might be effective in the management of post hysterectomy menopausal syndrome & improve quality of life of women underwent hysterectomy Subjective Parameters Menopausal Rating scale Modified Kuppermans Index Menopause Specific Quality of life Objective Parameter Serum estrogenTimepoint: Subjective parameter on 0th 15th 30th and 45th day Objective parameter on 0th and 45th day

Secondary

MeasureTime frame
Hamilton Anxiety Rating ScaleTimepoint: 0n 0th & 45th day

Countries

India

Contacts

Public ContactDr Kashavva Hiremath

KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi

drkvhiremath@gmail.com9448945687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026